Cited by 231Alzheimer's disease research and treatmentsProtease and Inhibitor MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease

Open access

Sun, Binggui, Zhou, Yungui, Halabisky, Brian, Lo, Iris, Cho, Seo-Hyun, Mueller-Steiner, Sarah, Devidze, Nino, Wang, Xin, Grubb, Anders, Gan, Li·2008·Neuron

DOI 10.1016/j.neuron.2008.10.001PMC PMC2755563

Open this paper in CoChat — free account Open PDF

Abstract

Impaired degradation of amyloid beta (Abeta) peptides could lead to Abeta accumulation, an early trigger of Alzheimer's disease (AD). How Abeta-degrading enzymes are regulated remains largely unknown. Cystatin C (CysC, CST3) is an endogenous inhibitor of cysteine proteases, including cathepsin B (CatB), a recently discovered Abeta-degrading enzyme. A CST3 polymorphism is associated with an increased risk of late-onset sporadic AD. Here, we identified CysC as the key inhibitor of CatB-induced Abeta degradation in vivo. Genetic ablation of CST3 in hAPP-J20 mice significantly lowered soluble Abeta levels, the relative abundance of Abeta1-42, and plaque load. CysC removal also attenuated Abeta-associated cognitive deficits and behavioral abnormalities and restored synaptic plasticity in the hippocampus. Importantly, the beneficial effects of CysC reduction were abolished on a CatB null background, providing direct evidence that CysC regulates soluble Abeta and Abeta-associated neuronal deficits through inhibiting CatB-induced Abeta degradation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2008.10.001

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856

Flagged first, then by citations

Show all 55 references

Sorted by citations

Items 101–200 of 231

Forgot to Exercise? Exercise Derived Circulating Myokines in Alzheimer's Disease: A Perspective
Gupta, R., Khan, R., & Cortés, C. J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.649452 · Cited by 37
Hippocampal Growth Factor and Myokine Cathepsin B Expression following Aerobic and Resistance Training in 3xTg-AD Mice
Pena, G. S., Paez, H. G., Johnson, T. K., Halle, J. L., Carzoli, J. P., Visavadiya, N. P., Zourdos, M. C., WHITEHURST, M. A., & Khamoui, A. V. (2020) · International Journal of Chronic Diseases · doi:10.1155/2020/5919501 · Cited by 38
SORLA-Dependent and -Independent Functions for PACS1 in Control of Amyloidogenic Processes
Burgert, T., Schmidt, V., Çağlayan, Ş., Lin, F., Füchtbauer, A. C., Füchtbauer, E., Nykjær, A., Carlo, A.-S., & Willnow, T. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00628-13 · Cited by 35
Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome
Morrone, C., Smirnova, N. F., Jeridi, A., Kneidinger, N., Hollauer, C., Schupp, J. C., Kaminski, N., Jenne, D. E., Eickelberg, O., & Yildirim, A. Ö. (2020) · European Respiratory Journal · doi:10.1183/13993003.01416-2020 · Cited by 33
The emerging neuroprotective roles of exerkines in Alzheimer’s disease
Rody, T., Amorim, J. A. D., & Felice, F. G. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.965190 · Cited by 37
Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
Sundelöf, J., Sundström, J., Hansson, O., Eriksdotter-Jönhagen, M., Giedraitis, V., Larsson, A., Degerman-Gunnarsson, M., Ingelsson, M., Minthon, L., Blennow, K., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091594 · Cited by 32
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
Toyn, J. H., & Ahlijanian, M. K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt244 · Cited by 31
The Role of Cysteine Protease in Alzheimer Disease
Hasanbašić, S., Jahić, A., Karahmet, E., Sejranic, A., & Prnjavorac, A. (2016) · Materia Socio Medica · doi:10.5455/msm.2016.28.235-238 · Cited by 31
Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways
Farizatto, K. L. G., Ikonne, U. S., de Almeida, M. F., Ferrari, M., & Bahr, B. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182895 · Cited by 33
Candidate gene analysis for Alzheimer's disease in adults with Down syndrome
Lee, J. H., Lee, A., Dang, L. T., Pang, D. I., Kisselev, S., Krinsky‐McHale, S. J., Zigman, W. B., Luchsinger, J. A., Silverman, W. P., Tycko, B., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.018 · Cited by 29
Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid
Perlenfein, T. J., Mehlhoff, J. D., & Murphy, R. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786558 · Cited by 31
The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia
Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025) · Glia · doi:10.1002/glia.70009 · Cited by 31
The emerging role of cystatins in Alzheimer's disease
Žerovnik, E. (2009) · BioEssays · doi:10.1002/bies.200900012 · Cited by 30
Long‐term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease
Alldred, M. J., Chao, H. M., Lee, S. H., Beilin, J., Powers, B. E., Petkova, E., Strupp, B. J., & Ginsberg, S. D. (2019) · The FASEB Journal · doi:10.1096/fj.201802669rr · Cited by 29
Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3
Yamamoto‐Watanabe, Y., Watanabe, M., Jackson, M. T., Akimoto, H., Sugimoto, K., Yasujima, M., Wakasaya, Y., Matsubara, E., Kawarabayashi, T., Harigaya, Y., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.033 · Cited by 30
Multimodal data integration via mediation analysis with high‐dimensional exposures and mediators
Zhao, Y., Li, L., & Initiative, A. D. N. (2022) · Human Brain Mapping · doi:10.1002/hbm.25800 · Cited by 25
Autophagy system as a potential therapeutic target for neurodegenerative diseases
Cui, M., Yoshimori, T., & Nakamura, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105308 · Cited by 29
Aberrant serotonergic signaling contributes to the hyperexcitability of CA1 pyramidal neurons in a mouse model of Alzheimer’s disease
Wang, J., Mei, Y., Zhang, X., Wei, X., Zhang, Y., Wang, D., Huang, J., Zhu, K., Peng, G., & Sun, B. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112152 · Cited by 30
Self-citation
The lysosome system is severely impaired in a cellular model of neurodegeneration induced by HSV-1 and oxidative stress
Kristen, H., Sastre, I., Muñoz‐Galdeano, T., Recuero, M., Aldudo, J., & Bullido, M. J. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.025 · Cited by 30
Ablating Adult Neural Stem Cells Improves Synaptic and Cognitive Functions in Alzheimer Models
Zhang, X., Mei, Y., He, Y., Wang, D., Wang, J., Wei, X., Yang, E., Zhou, D., Shen, H., Peng, G., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.12.003 · Cited by 30
Self-citation
Endosomal‐lysosomal dysfunctions in Alzheimer’s disease: Pathogenesis and therapeutic interventions
Lai, S. S. M., Ng, K. Y., Koh, R. Y., Chok, K. C., & Chye, S. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00737-0 · Cited by 31
Developmental Regulation of Synthesis and Dimerization of the Amyloidogenic Protease Inhibitor Cystatin C in the Hematopoietic System
Xu, Y., Lindemann, P., Vega‐Ramos, J., Zhang, J., & Villadangos, J. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538041 · Cited by 27
Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice
Biasizzo, M., Prebanda, M. T., Dolinar, K., Pirkmajer, S., Završnik, J., Turk, B., & Kopitar‐Jerala, N. (2021) · Cells · doi:10.3390/cells10082071 · Cited by 26
Nitroxyl in the Central Nervous System
Choe, C., Lewerenz, J., Gerloff, C. P., Magnus, T. U., & Donzelli, S. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3852 · Cited by 26
Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid
Boutté, A. M., HOOK, V. Y. H., Thangavelu, B., Sarkis, G. A., Abbatiello, B. N., Hook, G., Jacobsen, J. S., Robertson, C. S., Gilsdorf, J. S., Yang, Z., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6537 · Cited by 25
Amyloid β Is Not the Major Factor Accounting for Impaired Adult Hippocampal Neurogenesis in Mice Overexpressing Amyloid Precursor Protein
Pan, H., Wang, D., Zhang, X., Zhou, D., Zhang, H., Qian, Q., He, X., Liu, Z., Liu, Y., Zheng, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.019 · Cited by 26
Self-citation
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression
Zhang, Z., & Zhan, F. (2023) · Cancers · doi:10.3390/cancers15225363 · Cited by 25
The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration
Masi, M., Biundo, F., Fiou, A., Racchi, M., Pascale, A., & Buoso, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076639 · Cited by 28
Protein Conformational Pathology in Alzheimers and Other Neurodegenerative Diseases; New Targets for Therapy
Žerovnik, E. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274437 · Cited by 23
Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex
Viana, G. M., Gonzalez, E. A., Alvarez, M. M. P., Cavalheiro, R. P., do Nascimento, C. C., Baldo, G., D’Almeida, V., de Lima, M. A., Pshezhetsky, A. V., & Nader, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041459 · Cited by 23
Associations of serum cystatin C with depressive symptoms and suicidal ideation in major depressive disorder
Sun, T., Chen, Q., & Li, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03509-3 · Cited by 19
Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells
Wang, X., Liu, D., Liang, Y., Xing, L.-L., Zhao, W.-H., Qin, X., Shang, D., Li, B., Fang, W., Cao, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161093 · Cited by 22
Self-citation
Food Components with the Potential to be Used in the Therapeutic Approach of Mental Diseases
Fernández, M. J. F., Valero‐Cases, E., & Frutos‐Rincón, L. (2018) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201019666180925120657 · Cited by 20
Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C
Whelly, S., Serobian, G., Borchardt, C., Powell, J., Johnson, S., Håkansson, K., Lindström, V., Abrahamson, M., GRUBB, A. O., & Cornwall, G. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515759 · Cited by 19
Self-citation
Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity
Forest, K. H., & Nichols, R. A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.013 · Cited by 19
Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP
Pirici, D. N., Stanaszek, L., Garz, C., Niklass, S., Heinze, H., Kalinski, T., Attems, J., & Schreiber, S. (2016) · Brain Pathology · doi:10.1111/bpa.12384 · Cited by 19
Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease
Grimm, M. O. W., & Hartmann, T. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s5-004 · Cited by 20
Cathepsin B modulates microglial migration and phagocytosis of amyloid β in Alzheimer’s disease through PI3K-Akt signaling
Jiang, M., Zhao, D., Zhou, Y., Kong, W., Xie, Z., Xiong, Y., Li, Y., Zhao, S., Kou, X., Zhang, S., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01994-0 · Cited by 24
Self-citation
Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment
Hirao, K., Yamashita, F., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Kanetaka, H., Umahara, T., Sakurai, H., Hanyu, H., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201451 · Cited by 18
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Experimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18
Lifestyle strategies to promote proteostasis and reduce the risk of Alzheimer’s disease and other proteinopathies
de Almeida, M. F., Farizatto, K. L. G., Almeida, R. S., & Bahr, B. A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102162 · Cited by 17
Expression, purification, and characterization of human cystatin C monomers and oligomers
Perlenfein, T. J., & Murphy, R. M. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.09.023 · Cited by 17
Early Activation of Astrocytes does not Affect Amyloid Plaque Load in an Animal Model of Alzheimer’s Disease
Wang, D., Zhang, X., Wang, M., Zhou, D., Pan, H., Shu, Q., & Sun, B. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0262-2 · Cited by 17
Self-citation
Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren, Y., Zhu, W., Cui, F., Yang, F., Chen, Z., Li, L., & Huang, X. (2015) · PubMed Central · Cited by 17
Lysosomal Modulatory Drugs for a Broad Strategy Against Protein Accumulation Disorders
Bahr, B. A. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207903 · Cited by 17
A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation
Perlenfein, T. J., & Murphy, R. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811448 · Cited by 17
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
Wu, Y., Mumford, P., Noy, S., Cleverley, K., Mrzyglod, A., Luo, D., van Dalen, F., Verdoes, M., Fisher, E. M. C., & Wiseman, F. K. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01632-8 · Cited by 16
Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer’s disease
Li, Q., Li, B., Liu, L., Wang, K.-J., Liu, M., Deng, Y., Li, Z., Zhao, W., Wu, L., Chen, Y., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03119-2 · Cited by 15
Cathepsin B-A Neuronal Death Mediator in Alzheimer’s Disease Leading to Neurodegeneration
Singh, S. K., Sharma, A., Swetha, R., Bajad, N. G., Ganeshpurkar, A., Singh, R., & Kumar, A. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220214095859 · Cited by 16
Co-localization of cystatin C and prosaposin in cultured neurons and in anterior horn neurons with amyotrophic lateral sclerosis
Wada, Y., Nagai, A., Sheikh, A. M., Onoda, K., Terashima, M., Shiota, Y., Araki, A., & Yamaguchi, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.023 · Cited by 15
Platelet-activating factor antagonists enhance intracellular degradation of amyloid-β42 in neurons via regulation of cholesterol ester hydrolases
Simmons, C., Ingham, V. A., Williams, A., & Bate, C. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt245 · Cited by 15
Cathepsin B Modulates Alzheimer's Disease Pathology Through SAPK / JNK Signals Following Administration of Porphyromonas gingivalis‐Derived Outer Membrane Vesicles
Jiang, M., Ge, Z., Yin, S., Liu, Y., Gao, H., Lu, L., Wang, H., Chen, L., Ni, J., Pan, Y., et al. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14109 · Cited by 14
Cystatin C Triggers Neuronal Degeneration in a Model of Multiple System Atrophy
Suzuki, Y., Jin, C. H., & Yazawa, I. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.018 · Cited by 15
Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids
Gowrishankar, S., Cologna, S. M., Givogri, M. I., & Bongarzone, E. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105142 · Cited by 16
Aging, microglia and cytoskeletal regulation are key factors in the pathological evolution of the APP23 mouse model for Alzheimer's disease
Janssen, L., Dubbelaar, M. L., Holtman, I. R., de Boer-Bergsma, J. J., Eggen, B. J. L., Boddeke, H. W. G. M., Deyn, P. P. D., & Dam, D. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.014 · Cited by 13
Do Amyloid β-associated Factors Co-deposit with Aβ in Mouse Models for Alzheimer's Disease?
Timmer, N., Kuiperij, H. B., de Waal, R. M. W., & Verbeek, M. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100711 · Cited by 13
Cathepsin D: A Candidate Link between Amyloid ?-protein and Tauopathy in Alzheimer Disease
Suire, C. N., & Leissring, M. A. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.029 · Cited by 15
Cystatins: unravelling the biological implications for neuroprotection
Stańczykiewicz, B., Łuc, M., Banach, M., & Zabłocka, A. (2023) · Archives of Medical Science · doi:10.5114/aoms/171706 · Cited by 12
Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer's disease
Li, Z., Wong, L. R., Wong, P., Shen, W. X., Yang, S., Huang, L., Lim, Y.-A., & Ho, P. C. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100599 · Cited by 11
The aquaporin-4 water channel and updates on its potential as a drug target for Alzheimer’s disease
Silverglate, B., Gao, X., Lee, H., Maliha, P., & Grossberg, G. T. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2240017 · Cited by 11
Chaperone-Mediated Responses and Mitochondrial–Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer’s Disease
Singh, M. K., Fu, M., Han, S., Ranbhise, J. S., Choe, W., Kim, S. S., & Kang, I. (2025) · Cells · doi:10.3390/cells14151179 · Cited by 11
Endogenous aggregates of amyloidogenic cystatin C variant are removed by THP-1 cells in vitro and induce differentiation and a proinflammatory response
Jónsdóttir, G., Ingólfsdóttir, I. E., Thormodsson, F. R., & Petersen, P. H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.012 · Cited by 11
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease
Lowe, A. J., Sjödin, S., Rodrigues, F. B., Byrne, L. M., Blennow, K., Tortelli, R., Zetterberg, H., & Wild, E. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233820 · Cited by 11
Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment
Hirao, K., Yamashita, F., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Okita, M., Shimizu, S., Kanetaka, H., Umahara, T., et al. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13767 · Cited by 11
Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment
Hirao, K., Yamashita, F., Sakurai, S., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Kanetaka, H., Umahara, T., Sakurai, H., et al. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14211 · Cited by 10
Association between serum cystatin C level and cognition in older adults: a cross-sectional analysis
Wang, S., Lin, X., Zhou, J., Li, M., & Song, D. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1200763 · Cited by 9
Early Changes in Transcriptomic Profiles in Synaptodendrosomes Reveal Aberrant Synaptic Functions in Alzheimer’s Disease
Qu, X., Lin, L., Yi, W., Sun, C., Chen, Y., & Chen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168888 · Cited by 9
HCN2 deficiency correlates with memory deficits and hyperexcitability of dCA1 pyramidal neurons in Alzheimer’s disease
Zhang, X., Zhang, Y., Zhang, T., Wang, J., Liu, C., Shang, Q. S., Wei, X., Zhu, H., Shen, H., & Sun, B. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01704-y · Cited by 9
Self-citation
Cystatin C is differentially involved in multiple system atrophy phenotypes
Urbizu, A., Canet-Pons, J., Muñoz-Mármol, A. M., Aldecoa, I., Lopez, M. T., Compta, Y., Álvarez, R., Ispierto, L., TOLOSA, E. S., Ariza, A., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12134 · Cited by 8
Fibroblasts from PS1 Mutated Pre-Symptomatic Subjects and Alzheimer's Disease Patients Share a Unique Protein Levels Profile
Magini, A., Urbanelli, L., Ciccarone, V. A., Tancini, B., Polidoro, M., Timperio, A. M., Zolla, L., Tedde, A., Sorbi, S., & Emiliani, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091522 · Cited by 8
Cystatin F attenuates neuroinflammation and demyelination following murine coronavirus infection of the central nervous system
Syage, A. R., Pachow, C., Murray, K. M., Henningfield, C. M., Fernandez, K., Du, A. X., Cheng, Y., Olivarria, G. M., Kawauchi, S., MacGregor, G. R., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03153-0 · Cited by 7
An animal model of the procognitive properties of cysteine protease inhibitor and immunomodulatory peptides based on colostrum.
Stańczykiewicz, B., Jakubik, M., Polanowski, A., Trziszka, T., & Rymaszewska, J. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/62536 · Cited by 7
GSK-3 and lysosomes meet in Alzheimer’s disease
Avrahami, L., & Eldar-Finkelman, H. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.25179 · Cited by 7
Potential Alzheimer’s Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain
Romine, H., Rentschler, K. M., Smith, K., Edwards, A., Colvin, C., Farizatto, K. L. G., Pait, M. C., Butler, D., & Bahr, B. A. (2017) · European Scientific Journal ESJ · doi:10.19044/esj.2017.c1p5 · Cited by 7
Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects
Barbierato, M. (2012) · Padua Research Archive (University of Padova) · Cited by 6
Cystatin C is a glucocorticoid response gene predictive of cancer immunotherapy failurePreprint
Kleeman, S. O., Ferrer, M., Demestichas, B., Bankier, S., Lee, H., Heywood, T., Ruusalepp, A., Bjorkegren, J. L. M., Walker, B., Meyer, H. V., et al. (2021) · medRxiv · doi:10.1101/2021.08.17.21261668 · Cited by 4
Modeling endophilin-mediated Aβ disposal in glioma cells
Sun, B., Fan, P., Liao, M., & Zhang, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.06.015 · Cited by 5
Self-citation
The Lysosome in Aging‐Related Neurodegenerative Diseases
Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch9 · Cited by 5
Degraded Products of Stem Bromelain Destabilize Aggregates of β-Amyloid Peptides Involved in Alzheimer’s Disease
Mukherjee, D., Bhattacharjee, P., Bhattacharya, R., Dutta, A. K., & Bhattacharyya, D. (2018) · Current Science · doi:10.18520/cs/v115/i11/2133-2141 · Cited by 4
Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice
Stańczykiewicz, B., Gburek, J., Rutkowska, M., Lemieszewska, M., Gołąb, K., Juszczyńska, K., Piotrowska, A., Trziszka, T., Dzięgiel, P., Podhorska‐Okołów, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092372 · Cited by 4
Cystatin C Attenuates Perihematomal Secondary Brain Injury by Inhibiting the Cathepsin B/NLRP3 Signaling Pathway in a Rat Model of Intracerebral Hemorrhage
Zhou, Y., Dong, W., Wang, L., Ren, S., Wei, W., & Wu, G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04195-4 · Cited by 4
Self-citation
Lysosomal proteases and their role in signaling pathways
Bose, S. J., Ayagama, T., & Burton, R. A. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85696-6.00007-x · Cited by 4
Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice
Stańczykiewicz, B., Jakubik, M., Rutkowska, M., Polanowski, A., Gburek, J., Gołąb, K., Juszczyńska, K., Trziszka, T., & Rymaszewska, J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.002 · Cited by 4
Proteinase inhibitors in the cerebrospinal fluid in neurological diseases
Brylev, L. (2009) · Neurochemical Journal · doi:10.1134/s1819712409030106 · Cited by 4
Lysosomal enzyme tripeptidyl peptidase 1 plays a role in degradation of beta amyloid fibrilsPreprint
Cruz, D. L., El-Banna, M., Majumdar, A., Sleat, D. E., Muldowney, M., Lobel, P., & Maxfield, F. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/639682 · Cited by 4
Haploinsufficiency of lysosomal enzyme genes in Alzheimer’s diseasePreprint
Benítez, B. A., Wallace, C. E., Patel, M., Nykänen, N.-P., Yuede, C. M., Eaton, S. L., Pottier, C. P., Cetin, A., Johnson, M., Bevan, M. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.16.623962 · Cited by 4
Cathepsin B deficiency disrupts cortical development via PEG3, leading to depression-like behavior
Xie, Z., Yang, Q., Lan, F., Kong, W., Zhao, S., Sun, J., Yan, Y., Quan, Z., Bai, Z., Qing, H., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08508-8 · Cited by 3
Autophagy, the “Master” Regulator of Cellular Quality Control: What Happens when Autophagy Fails?
Raquel, A., Catarina, R. A., & Morais, S. (2013) · InTech eBooks · doi:10.5772/55196 · Cited by 4
AUTOPHAGY FAILURE IN ALZHEIMER’S DISEASE AND LYSOSOMAL STORAGE DISORDERS: A COMMON PATHWAY TO NEURODEGENERATION?
Wolfe, D. M., & Nixon, R. A. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814350457_0010 · Cited by 3
Cathepsin B inhibition blocks amyloidogenesis in the mouse models of neurological lysosomal diseases MPS IIIC and sialidosis
Viana, G. M., Pan, X., Fan, S., Xu, T., Wyatt, A., & Pshezhetsky, A. V. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101432 · Cited by 2
Soluble Expression of Recombinant Human Cystatin C and Comparison of the Ni Column and Magnetic Bead Purification
Zhang, Y., Zhao, J., He, S., & Cao, X. (2019) · The Protein Journal · doi:10.1007/s10930-019-09873-0 · Cited by 2
Autophagy and Neurodegenerative Diseases
Paek, J., & Kim, B.-S. (2009) · Cited by 2
Production of Cystatin C Wild Type and Stabilized Mutants.
Pollak, J., Szymańska, A., Lindström, V., & GRUBB, A. O. (2010) · PubMed Central · Cited by 2
Self-citation
Autophagy Enhancers, are we there Yet?
Lu, S., & Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch14 · Cited by 2
Identification of Regulatory Elements in Primary Sensory Neurons Involved in Trauma-Induced Neuropathic Pain
Stephens, K., Moore, C., Vinson, D. A., White, B. E., Renfro, Z. T., Zhou, W., Ji, Z., Ji, H., Zhu, H., Guan, Y., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03673-5 · Cited by 1
Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models
Wu, Y., Cleverley, K., & Wiseman, F. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316822 · Cited by 1
Deposition of aggregated cystatin C-amyloid-β complexes and reduced cathepsin B activity modulate cerebral amyloid angiopathy pathogenesis
Bhuiya, J., Shibly, A. Z., Sheikh, A. M., Tabassum, S., Abdullah, F. B., Fahmida, J., Tamegai, H., Aritake, S., Yano, S., & Nagai, A. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf138 · Cited by 1
A review of plant-derived products regulating amyloid beta-degrading enzymes in Alzheimer’s disease
Honaramouz, B., Imenshahidi, M., & Hosseinzadeh, H. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158053 · Cited by 1
A Single Pathway Targets Several Health Challenges of the Elderly
Bahr, B. A. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1585 · Cited by 1

Authors: Sun, B., Zhou, Y., Halabisky, B., Lo, I., Cho, S.-H., Mueller-Steiner, S., Devidze, N., Wang, X., Grubb, A., & Gan, L.
Affiliations: University of California, San Francisco (US)
Skåne University Hospital (SE)
Corresponding author: Gan, Li
ORCID: Sun, Binggui
Lo, Iris
Grubb, Anders
Gan, Li
Venue: Neuron
Publisher: Elsevier BV
Published: 2008-10
Volume: 60
Issue: 2
Pages: 247-257
ISSN: 0896-6273 (ISSN-L)
DOI: 10.1016/j.neuron.2008.10.001
PMC: PMC2755563
OpenAlex: W2039502252
Cited by: 231
References: 55
Citations by year: 2026: 10 · 2025: 10 · 2024: 10 · 2023: 17 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 10 · 2018: 15 · 2017: 21 · 2016: 13 · 2015: 8 · 2014: 15 · 2013: 15 · 2012: 11
FWCI: 9.28
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1750 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Neuron (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Lund University Publications (Lund University) (submittedVersion)
Funders: Gladstone Institutes
Vetenskapsrådet
National Institutes of Health (1c06rr018928-01)
National Institute on Aging (R21AG024447, AG024447)
National Center for Research Resources (C06-RR-018928)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: cystatin C, cathepsin B, amyloid-beta, Alzheimer's disease, amyloid beta degradation, cysteine protease inhibition, amyloid plaques, cognitive impairment, synaptic plasticity, hippocampus
MeSH terms: Alzheimer Disease, Animals, Brain, Cathepsin B, Peptide Fragments, Polymorphism, Genetic, Amyloid beta-Peptides, Mice, Knockout, Genetic Predisposition to Disease, Mice, Cystatin C, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks